National and Kapodistrian University of Athens
Η διερεύνηση του ρόλου των τεχνικών φωτομικροεξάχνωσης για την αντιμετώπιση των γυναικών με ουρογεννητικό σύνδρομο της εμμηνόπαυσης
Abstract
dc:descriptionAIM OF THE STUDY: The aim of the current study is to assess the effectiveness of microablative fractional CO2-laser therapy for the management of genitourinary syndrome of menopause (GSM). METHODS: Three intravaginally administered therapies of CO2 – laser (1 therapy/month) were applied in postmenopausal women with ≥1 moderate/severe intensity of GSM symptoms. Women had to have clinical signs of GSM as well. Primary outcomes of the study were the Vaginal Maturation Value (VMV) and the Vaginal Health Index (VHI). Secondary outcomes were symptoms from the lower genital [by a 10-cm Visual Analogue Scale (10-cm VAS)] and lower urinary tract system (by validated condition specific questionnaires), sexual health [by Female Sexual Function Index (FSFI)], women’s quality of life and impression regarding the CO2-laser therapy, pH of the vaginal fluid and the vaginal microenvironment. All comparisons were performed between values of outcomes before the initiation of the laser therapy (baseline) and 1-month following the completion of the protocol (12-weeks follow-up). RESULTS: Fifty-three postmenopausal women (mean age 57.2±5.4) were eligible to be included in the current protocol. At 12-weeks follow-up all outcomes (primary and secondary) were statistically and clinically significantly improved compared to the baseline. Thus, VMV improved from 11.7±15.6 at baseline to 44.2±13.7 at 12-weeks follow-up (p-value <0.001), dyspareunia decreased from 7.7±2.5 to 2.3±2.2 (p-value <0.001), dryness decreased from 6.1±3.1 to 1.7±1.9 (p-value <0.001), while sexual health increased from 13.7± 8.1 to 25.9±4.6 (p-value <0.001). At the end of the therapeutic protocol all women (100%) declared very satisfied/satisfied with the treatment, while 90% of women reported that they felt very much better/much better in comparison to the baseline. CONCLUSION: The efficacy of CO2-laser was assessed for the first time with a holistic approach using objective and subjective measures. The results of this study indicate that intravaginally administered CO2-laser therapy is promising for the management of GSM as it may improve the local pathophysiology as well as all GSM symptoms. High quality randomized controlled trials are needed for the results of this study to be confirmed.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pitsouni, Eleni
- Πιτσούνη, Ελένη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45776